Abiomed (ABMD) Guides Q3 Revenue Above the Street

Abiomed, Inc. (NASDAQ: ABMD) reported preliminary unaudited third quarter fiscal 2016 revenue of approximately $85.8 million, an increase of 38% compared to revenue of $62.0 million for the same period of fiscal 2015. *** The consensus is $79 million.

• Preliminary unaudited U.S. revenue from Impella® products grew 45% to approximately $75.0 million from $51.9 million in the prior fiscal year.
• For the third quarter of fiscal 2016, U.S. patient usage grew 45% in comparison with same period of fiscal 2015.

The preliminary unaudited revenue results described in this press release are estimates only and are subject to revision until the Company reports its full financial results for the third quarter of fiscal 2016 on February 4, 2016. Abiomed will also update its fiscal 2016 guidance on the February 4 conference call. The Company’s fiscal year ends on March 31, 2016.

These preliminary results are being provided in advance of the Company's presentation at the 34th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. Michael R. Minogue, Chairman, President and Chief Executive Officer, Abiomed, will present at 7:30 a.m. PT/10:30 a.m. ET on Wednesday, January 13, 2016.

A live webcast of the Company's presentation at the conference will be available via http://investors.abiomed.com/events.cfm. A replay of the webcast will be available for 90 days after the presentation.

EARNINGS CONFERENCE CALL DETAILS

The Company will release full quarterly results for the third quarter of fiscal 2016 and update the fiscal 2016 guidance via conference call on Thursday, February 4, 2016.

The conference call releasing full quarterly results will be hosted by Michael R. Minogue, Chairman, President and Chief Executive Officer and Michael Tomsicek, Vice President and Chief Financial Officer.

To listen to the call live, please tune into the webcast via http://investor.abiomed.com or dial (855) 212-2361; the international number is (678) 809-1538. A replay of this conference call will be available beginning at 11 a.m. EST February 4, 2016 through 11:59 p.m. EST on February 6, 2016. The replay phone number is (855) 859-2056; the international number is (404) 537-3406. The replay access code is 3101592.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Phillips Edison & Company (PECO) Reports In-Line Q1 EPS, provides guidance
• L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance